Innovations in Progress
The journey of every person living with diabetes is personal and unique.
Diabetes management can vary greatly from person-to-person, creating multiple market segments based on clinical needs and personal preferences. Our goal is to redefine global leadership in insulin delivery with an accessible portfolio of transformational devices, applications and services that reduce the daily burden of living with diabetes.
In support of this strategy, our portfolio of future technologies includes enhancing the features and capabilities of our t:slim X2 and Tandem Mobi insulin pump platforms, including adding a tubeless infusion site option for Tandem Mobi users. Our development efforts also include Sigi, our ergonomic and rechargeable patch pump, in addition to extended wear infusion technology and algorithm advancement in pursuit of offering fully closed loop technology.
Note: The information on this page discusses products that may not be approved by the FDA. This information is intended for people researching the company, and is updated in conjunction with public announcements about our product innovations. All dates and information are as of February 26, 2025. Tandem Diabetes Care undertakes no obligation to update or review any forward-looking information below based on new information, future events, or other factors.